RAPT Therapeutics, Inc. (RAPT) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 886K | 641K | 756K | 966K | 869K | 1.22M | 1.3M |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | 1.96% | -47.55% | -41.94% | -36.78% | -31.95% | 30.7% | - |
| Cost of Goods Sold | 0 | 200K | 0 | 0 | 0 | 0 | 314K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -200K | 0 | 0 | 0 | 0 | -314K | 0 | 0 | 0 | 0 | 0 | 0 | 886K | 641K | 756K | 966K | 869K | 1.22M | 1.3M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | - | 100% | - | - | - | - | - | - | -100% | -100% | -100% | -100% | 1.96% | -47.55% | -41.94% | -36.78% | -31.95% | 30.7% | - |
| Operating Expenses | 19.37M | 19.34M | 19.27M | 54.47M | 19.79M | 29.33M | 32.2M | 33.22M | 33.92M | 28.36M | 31.56M | 24.43M | 21.68M | 19.8M | 21.42M | 18.79M | 19.5M | 16.95M | 17.78M | 14.39M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 2234.2% | 3341.34% | 2485.45% | 2018.53% | 1950.52% | 1455.24% | 1104.99% |
| Selling, General & Admin | 7.34M | 7.2M | 7.22M | 8.01M | 6.45M | 6.69M | 7.42M | 6.45M | 6.9M | 6.72M | 5.99M | 4.98M | 5.08M | 5.44M | 4.75M | 4.49M | 3.77M | 3.76M | 4.01M | 3.48M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 613.54% | 740.72% | 594.05% | 390.68% | 432.68% | 328.31% | 267.51% |
| Research & Development | 12.03M | 12.34M | 12.04M | 46.46M | 13.34M | 22.64M | 24.78M | 26.76M | 27.02M | 21.64M | 25.57M | 19.45M | 16.6M | 14.36M | 16.67M | 14.3M | 15.72M | 13.19M | 13.77M | 10.9M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 1620.65% | 2600.62% | 1891.4% | 1627.85% | 1517.84% | 1126.92% | 837.48% |
| Other Operating Expenses | 0 | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.37M | -19.54M | -19.27M | -54.47M | -19.79M | -29.33M | -32.52M | -33.22M | -33.92M | -28.36M | -31.56M | -24.43M | -21.68M | -18.91M | -20.78M | -18.03M | -18.53M | -16.08M | -16.56M | -13.09M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -2134.2% | -3241.34% | -2385.45% | -1918.53% | -1850.52% | -1355.24% | -1004.99% |
| Operating Income Growth % | 2.11% | 33.4% | 40.76% | -63.97% | 41.66% | -3.41% | -3.03% | -35.96% | -56.47% | -50% | -51.91% | -35.47% | -16.97% | -17.59% | -25.46% | -37.82% | -27.1% | -28.53% | -27.03% | -2.11% |
| EBITDA | -19.17M | -19.34M | -19.01M | -54.18M | -19.49M | -29.02M | -32.2M | -32.89M | -33.59M | -28.09M | -31.26M | -24.18M | -21.42M | -18.64M | -20.52M | -17.8M | -18.3M | -15.82M | -16.28M | -12.82M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -2103.27% | -3200.62% | -2354.89% | -1894.82% | -1821.06% | -1332.32% | -984.64% |
| EBITDA Growth % | 1.67% | 33.38% | 40.96% | -64.7% | 41.98% | -3.31% | -3.01% | -36.04% | -56.85% | -50.76% | -52.38% | -35.81% | -17.01% | -17.76% | -26.01% | -38.87% | -27.84% | -30.62% | -26.82% | -2.59% |
| D&A (Non-Cash Add-back) | 205K | 200K | 252K | 287K | 297K | 305K | 314K | 323K | 325K | 269K | 299K | 252K | 260K | 274K | 261K | 231K | 229K | 256K | 280K | 265K |
| EBIT | -17.58M | -17.64M | -19.27M | -54.47M | -19.79M | -29.33M | -32.52M | -33.22M | -33.92M | -28.36M | -31.56M | -24.43M | -21.68M | -18.91M | -20.78M | -18.03M | -18.53M | -16.08M | -16.56M | -13.09M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.79M | 1.89M | 2.1M | 1.22M | 1.36M | 1.67M | 2M | 2.34M | 2.55M | 3.08M | 2.29M | 1.48M | 443K | -275K | 309K | 105K | -118K | -29K | 47K | 549K |
| Pretax Income | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M | -21.23M | -19.18M | -20.47M | -17.93M | -18.65M | -16.11M | -16.51M | -12.54M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -2165.24% | -3193.14% | -2371.56% | -1930.75% | -1853.86% | -1351.39% | -962.83% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 199K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -1.59% |
| Net Income | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M | -21.23M | -19.18M | -20.47M | -17.93M | -18.65M | -16.11M | -16.51M | -12.73M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -2165.24% | -3193.14% | -2371.56% | -1930.75% | -1853.86% | -1351.39% | -978.11% |
| Net Income Growth % | 4.62% | 36.22% | 43.76% | -72.46% | 41.25% | -9.43% | -4.27% | -34.53% | -47.73% | -31.78% | -43.01% | -28.01% | -13.85% | -19.08% | -23.94% | -40.79% | -27.48% | -30.06% | -25.69% | 3.64% |
| Net Income (Continuing) | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M | -21.23M | -19.18M | -20.47M | -17.93M | -18.65M | -16.11M | -16.51M | -12.73M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.65 | -0.65 | -0.64 | -9.12 | -3.79 | -5.69 | -6.32 | -6.44 | -6.54 | -5.28 | -6.12 | -5.14 | -5.04 | -4.93 | -5.54 | -4.86 | -5.06 | -5.04 | -5.32 | -4.14 |
| EPS Growth % | 82.85% | 88.5% | 89.92% | -41.79% | 42.07% | -7.91% | -3.34% | -25.09% | -29.73% | -7.06% | -10.48% | -5.95% | 0.32% | 2.14% | -4.13% | -17.16% | -5.68% | -23.68% | -17.7% | 11.63% |
| EPS (Basic) | -0.65 | -0.65 | -0.64 | -9.12 | -3.79 | -5.69 | -6.32 | -6.44 | -6.54 | -5.28 | -6.12 | -5.14 | -5.04 | -4.93 | -5.54 | -4.86 | -5.06 | -5.04 | -5.32 | -4.14 |
| Diluted Shares Outstanding | 26.96M | 26.95M | 26.93M | 5.84M | 4.86M | 4.86M | 4.83M | 4.8M | 4.79M | 4.79M | 4.79M | 4.46M | 4.21M | 3.89M | 3.7M | 3.69M | 3.69M | 3.2M | 3.11M | 3.07M |
| Basic Shares Outstanding | 26.96M | 26.95M | 26.93M | 5.84M | 4.86M | 4.86M | 4.83M | 4.8M | 4.79M | 4.79M | 4.79M | 4.46M | 4.21M | 3.89M | 3.7M | 3.69M | 3.69M | 3.2M | 3.11M | 3.07M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |